Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
European Urology|June 21, 2002
Molecular aspects of bladder cancer IV: gene therapy of bladder cancerPeter Ardelt, Andreas BöhleBiomarkers in Medicine|March 15, 2017
Influence of hematuria and infection on diagnostic accuracy of urinary LASP1: a new biomarker for bladder carcinomaElke Butt, Jan Ebbing, Lukas Bubendorf, et al.Current Urology Reports|June 27, 2002
Immune gene therapy in urologyIngo Kausch, Peter Ardelt, Andreas Böhle, et al.Urologic Oncology|April 7, 2012
LASP-1, a novel urinary marker for detection of bladder cancerPeter Ardelt, Nadine Grünemay, Annette Strehl, et al.Journal of Endourology|December 7, 2011
Retrograde intrarenal surgery in treatment of nephrolithiasis: is a 100% stone-free rate achievable?Martin Schoenthaler, Konrad Wilhelm, Arndt Katzenwadel, et al.BMC Nephrology|February 6, 2019
Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancerJan Ebbing, Felix Menzel, Paolo Frumento, et al.Scientific Reports|June 1, 2018
Oncological outcomes, quality of life outcomes and complications of partial cystectomy for selected cases of muscle-invasive bladder cancerJan Ebbing, Robin Colja Heckmann, Justin William Collins, et al.Plos One|January 9, 2016
Dynamics of Urinary Calprotectin after Renal IschaemiaJan Ebbing, Felix S Seibert, Nikolaos Pagonas, et al.European Urology Focus|September 12, 2025
Single-dose Versus 3-day Antimicrobial Prophylaxis in Transurethral Resection or Photoselective Vaporization of the Prostate: A Multicenter, Randomized, Placebo Controlled Trial (CITrUS Trial)Kathrin Bausch, Benjamin Speich, Deborah R Vogt, et al.Urologic Oncology|September 19, 2016
The efficacy of BCG TICE and BCG Connaught in a cohort of 2,099 patients with T1G3 non-muscle-invasive bladder cancerJ Alfred Witjes, Guido Dalbagni, Robert J Karnes, et al.Pageof 2